Results 161 to 170 of about 10,789,024 (363)
An Analysis of One Hundred and Fifty Cases of Cardiovascular Disease in World War II Veterans [PDF]
Aaron H. Traum, Blanche B. Wilcox
openalex +1 more source
Recent Applications of Mesoporous Silica Nanoparticles in Gene Therapy
The review summarizes the synthesis of mesoporous silica nanoparticles (MSNs) with modifiable surface properties, functionalization strategies, mechanism of therapeutic payload release, and current applications in gene therapy, focusing on their capabilities in the targeted delivery of therapeutic nucleic acids, CRISPR‐Cas systems, and other genetic ...
Tamanna Binte Huq+4 more
wiley +1 more source
ANESTHESIA FOR URGENT INTRA-ABDOMINAL SURGICAL PROCEDURES IN PATIENTS WITH CARDIOVASCULAR DISEASE [PDF]
Norman P. Johnson+1 more
openalex +1 more source
AIMSPec‐LoC is a novel lab‐on‐a‐chip platform integrating size‐based extracellular vesicle (EVs) separation with label‐free Raman spectroscopy and AI‐powered classification via SKiNET. This high‐throughput, portable system enables real‐time, multiplexed molecular fingerprinting of EVs from biofluids, offering transformative potential for early, non ...
Emma Buchan+3 more
wiley +1 more source
This review highlights recent advances in microfluidic technologies for modeling human aging and age‐related diseases. It explores how organ‐on‐chip platforms improve physiological relevance, enable rejuvenation strategies, facilitate drug screening, detect senescent cells, and identify biomarkers.
Limor Zwi‐Dantsis+5 more
wiley +1 more source
I. Cardiovascular Disease—With Particular Attention to Atherosclerosis
Robert E. Olson
openalex +2 more sources
The Electrocardiographic Recognition of Ventricular Hypertrophy in Congenital Cardiovascular Disease during the First Year of Life [PDF]
J. S. Oldham
openalex +1 more source
Advanced Oral Delivery Systems for Nutraceuticals
Emerging delivery technologies are explored to overcome barriers to oral nutraceutical absorption. Traditional carriers are compared with novel platforms including biodegradable polymers, MOFs, MPNs, and 3D printing. These systems enhance bioavailability, control release, and enable personalized nutrition.
Xin Yang+4 more
wiley +1 more source